Price$39.04-1.46 (-3.60%)
01:30 PM04:45 PM
News · 26 weeks39+25%
2025-12-142026-06-07
Mix2290d
- Insider10(45%)
- SEC Filings7(32%)
- Earnings2(9%)
- Other1(5%)
- Leadership1(5%)
- Analyst1(5%)
Latest news
25 items- SECSEC Form PREC14A filed by Genesco Inc.PREC14A - GENESCO INC (0000018498) (Subject)
- SECAmendment: SEC Form 10-K/A filed by Genesco Inc.10-K/A - GENESCO INC (0000018498) (Filer)
- SECGenesco Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - GENESCO INC (0000018498) (Filer)
- PRGenesco Inc. Reports Fiscal 2027 First Quarter Results--Sales and Bottom Line Improvement Exceed Expectations-- -- Journeys Comparable Sales +5%, Johnston & Murphy Comparable Sales +7%-- --Seventh Consecutive Quarter of Positive Total Comparable Sales Growth-- --Announces New $40 to $50 million Cost Savings Program-- --Raises Full Year EPS Outlook Range to $2.00 to $2.40-- Genesco Inc. (NYSE:GCO) today reported first quarter results for the three months ended May 2, 2026. First Quarter Fiscal 2027 Financial Summary Net sales of $487 million increased 3% compared to Q1FY26 Comparable sales increased 2%, with stores up 3% while e-commerce was flat Gross margin improved 30 basis points compared to last year Selling and administrat
- ANALYSTGenesco downgraded by Seaport Research PartnersSeaport Research Partners downgraded Genesco from Buy to Neutral
- PRGenesco to Report First Quarter Fiscal 2027 Financial Results and Hold Conference Call on May 29, 2026Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the first quarter fiscal 2027 on May 29, 2026, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the first quarter fiscal 2027 results will be available on the Genesco website on May 29, 2026 at https://www.genesco.com/investor-relations/investor-overv
- INSIDERNew insider Randolph Ashley Marie claimed ownership of 7,879 shares (SEC Form 3)3 - GENESCO INC (0000018498) (Issuer)
- SECGenesco Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - GENESCO INC (0000018498) (Filer)
- PRGenesco Names Ashley Randolph Vice President and Chief Accounting OfficerGenesco Inc. (NYSE:GCO) today announced the appointment of Ashley Randolph as Vice President and Chief Accounting Officer, effective May 5, 2026. A 20-year veteran of Genesco, Randolph most recently served as Vice President and Corporate Controller, a role she has held since 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505092710/en/Ashley Randolph - Genesco In her new role, Randolph will oversee the Company's accounting operations, financial controls and compliance, including financial statements, accounting policy, and SEC reporting, while driving continued efficiencies across the function. "Ashley is a greatly res
- SECGenesco Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - GENESCO INC (0000018498) (Filer)
- INSIDERSEC Form 4 filed by Becker Scott E4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Ewoldsen Daniel E4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Vaughn Mimi Eckel4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Gray Andrew4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Desai Parag4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Ewoldsen Daniel E4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Becker Scott E4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Gray Andrew4 - GENESCO INC (0000018498) (Issuer)
- INSIDERSEC Form 4 filed by Vaughn Mimi Eckel4 - GENESCO INC (0000018498) (Issuer)
- SECGenesco Inc. filed SEC Form 8-K: Leadership Update8-K - GENESCO INC (0000018498) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Genesco Inc.SCHEDULE 13G/A - GENESCO INC (0000018498) (Subject)
- SECSEC Form 10-K filed by Genesco Inc.10-K - GENESCO INC (0000018498) (Filer)
- SECGenesco Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - GENESCO INC (0000018498) (Filer)
- PRGenesco Inc. Reports Fiscal 2026 Fourth Quarter and Full Year Results--Journeys Q4 Comparable Sales +12%, Overall Comparable Sales +9%-- --Sixth Consecutive Quarter of Positive Comparable Sales Growth-- --Operating Income Increased 11% for Q4 and Increased 24% for Fiscal 2026-- Genesco Inc. (NYSE:GCO) today reported fourth quarter and full fiscal year results for the three and twelve months ended January 31, 2026. Fourth Quarter Fiscal 2026 Financial Summary Net sales of $800 million increased 7% compared to Q4FY25 Comparable sales increased 9%, with stores up 9% and e-commerce up 8% E-commerce sales represented 31% of retail sales compared to 30% last year Selling and administrative expenses leveraged 140 basis points compared to last year
- PREstablishment Labs Announces Leadership Transition to Support Next Phase of GrowthEstablishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum
GCO FAQ
6 questionsWhat does Genesco Inc. do?
Genesco Inc. operates as a retailer and wholesaler of footwear, apparel, and accessories. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children. The Schuh Group segment operates Schuh retail footwear stores that offer casual and athletic footwear, as well as sells footwear through e-commerce. The Johnston & Murphy Group...Where does GCO stock trade?
Genesco Inc. (GCO) is listed on NYSE.What sector and industry is GCO in?
Genesco Inc. operates in the Consumer Discretionary sector, Clothing/Shoe/Accessory Stores industry.What are analysts saying about GCO?
Genesco Inc. has had 8 recent analyst actions on file. The most recent action was from Seaport Research Partners: Neutral on 2026-05-27. Recent price targets range from $2300.00 to $4300.00.What companies are similar to GCO?
Notable peers in the same industry include TJX (TJX Companies Inc.), ROST (Ross Stores Inc.), GAP (Gap Inc.), GPS (Gap Inc.), URBN (Urban Outfitters Inc.). Compare GCO side-by-side with any of them on Quantisnow.How can I track GCO on Quantisnow?
Quantisnow aggregates Genesco Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GCO to receive live email and push alerts on every new disclosure.